FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Gly topics
Door Assembly
Swimming Goggles
Transverse
Alkoxylate
Fluoropolymer
Air Cleaning
Rotor Shaft
Aspect Ratio
Disconnect
Synchronization
Remote Control
Ethylene Glycol
Surfactant
Combustion
Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Gly patents



      
           
This page is updated frequently with new Gly-related patent applications. Subscribe to the Gly RSS feed to automatically get the update: related Gly RSS feeds. RSS updates for this page: Gly RSS RSS


Date/App# patent app List of recent Gly-related patents
11/13/14
20140336413
 Novel crystalline polymorphs of acetyl-glycine-beta-alanine and process of making the same patent thumbnailNovel crystalline polymorphs of acetyl-glycine-beta-alanine and process of making the same
This invention discloses novel crystalline polymorphs of acetyl-glycine-beta-alanine and process of making the same. The mentioned crystalline polymorphs can exhibit excellent purity and storage stability according to this invention.
11/13/14
20140336278
 In situ gelling drug delivery system patent thumbnailIn situ gelling drug delivery system
The invention provides liquid controlled-release drug delivery compositions which gel upon injection into the body to form, in situ, controlled-release drug implants. The compositions of the invention feature a gel-forming polymer that is insoluble in water, a polyethylene glycol solvent in which the polymer is dissolved, and the drug substance to be delivered..
11/13/14
20140336228
 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases patent thumbnailPharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4s,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and a calcium channel blocker or a fibrate as active ingredients.. .
11/13/14
20140336140
 Methods for providing sialylated oligosaccharides patent thumbnailMethods for providing sialylated oligosaccharides
The invention relates to a method for providing analogs of human milk oligosaccharides (hmo), in particular oligosaccharides containing terminal sialic acid. The method comprises the steps of: a) providing a source of non-digestible galactooligosaccharides (gos) containing at least two terminally bonded β-linked galactose residues; b) providing a sialic acid donor having (α2-3)-sialylated o-glycans; c) contacting said gos with said sialic acid donor in the presence of an enzyme having trans-sialidase activity in an enzyme reaction mixture; and d) isolating from said enzyme reaction mixture a fraction comprising at least 20 percent by weight of disialylated galactooligosaccharides (di-sia-gos) based on the dry matter..
11/13/14
20140336124
 Compositions for regenerating defective or absent myocardium patent thumbnailCompositions for regenerating defective or absent myocardium
Injectable collagen based graft compositions and grafts formed from the compositions for tissue regeneration. The compositions and grafts further include a glycosaminoglycan (gag) to control matrix formation and remodeling..
11/13/14
20140336114
 Buffers for controlling the ph of bone morphogenetic proteins patent thumbnailBuffers for controlling the ph of bone morphogenetic proteins
The present invention provides formulations of cysteine knot proteins, including tgf-β superfamily proteins and bone morphogenic proteins that are ph stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including tgf-β superfamily proteins and bone morphogenic proteins.
11/13/14
20140336113
 Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome patent thumbnailCompositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome
The present invention relates to compositions and methods for treating diseases associated with dyslipidemia, including hypercholesterolemia, hypertriglyceridemia, steatohepatitis, atherosclerosis, obesity, hyperglycemia, metabolic syndrome, and related aspects of and conditions associated with metabolic syndrome. The compositions and methods disclosed herein are useful for regulating the lipid balance (lipid homeostasis) in a subject.
11/13/14
20140336095
 Solid surfactant composition patent thumbnailSolid surfactant composition
A surfactant product is in the form of a solid. The surfactant product includes (i) sodium carbonate; (ii) cream of tartar; (iii) glycerine; (iv) sodium lauryl sulphate in an amount of from 3 to 15 wt % based on the weight of the total composition, and (v) sodium laureth sulphate in an amount of from 10 to 25 wt % based on the weight of the total composition..
11/13/14
20140335578
 Integrated biodiesel process patent thumbnailIntegrated biodiesel process
Methods of using crude glycerol to make fatty acids are provided, as well as integrated methods of converting glycerol waste from biodiesel production into more biodiesel. Bacteria and other microbes engineered to produce free fatty acids from glycerol are also provided..
11/13/14
20140335540
 Method of diagnosing bacterial infections using bacterial glycoproteins patent thumbnailMethod of diagnosing bacterial infections using bacterial glycoproteins
The present application provides a method of diagnosing bacterial infections using engineered glycoproteins in an immunoassay. The engineered bacterial glycoproteins used in the immunoassay comprise a bacterial antigen covalently attached to a protein via polysaccharyltransferase (ptase)-mediated glycosylation, wherein the bacterial antigen is selected based on the bacterial infection of interest.
11/13/14
20140335535
Peptide marker for cancer diagnosis and cancer diagnosis method using the same
The present invention relates to a peptide marker for cancer diagnosis and a cancer diagnosis method using the same, more precisely to a peptide marker for cancer diagnosis screened by the following steps: separating and concentrating glycoproteins including a certain glycan chain related to the occurrence of cancer; hydrolyzing the glycoproteins to obtain polypeptides; and quantitatively analyzing the polypeptides to identify certain polypeptides that can track quantitative changes in glycoproteins glycosylated in a specific manner by the occurrence of cancer, and to a cancer diagnosis method using the said peptide marker.. .
11/13/14
20140335477
Composition and method of using medicament for endodontic irrigation, stem cell preparations and tissue regeneration
A single intra-canal substance composition for tissue dissolution, disinfection, tissue degradation, tissue removal and disinfection is provided. The composition includes calcium hydroxide, sodium hydroxide, potassium thioglycolate or calcium thioglycolate, to form an effective single intra-canal substance capable of degrading a cell by disrupting its disulfide bonds.
11/13/14
20140335260
Lipid composition
A lipid composition having 90% or greater of a triglyceride mixture and 10% or less of a mixture comprising phospholipids and emulsifiers. Based on a total fatty acid content of the triglyceride mixture, the triglyceride mixture includes 95% or greater of c16-c22 fatty acid and 5% or less of c4-c14 fatty acid..
11/13/14
20140335229
Glycerol derived material
A method of producing a solid glycerol derived material includes the steps of combining glycerol with a metal oxide, the glycerol having a water content of between about 5 and 50%, and the rate of combination of the glycerol and the metal oxide and the amount of the metal oxide being selected so that at least part of the water present in the glycerol reacts with the metal oxide in an exothermic reaction and at least part is driven off by heat produced in the exothermic reaction to produce the solid glycerol derived material.. .
11/13/14
20140335151
Patch containing non-steroidal anti-inflammatory drug
The present invention is directed to a patch containing a non-steroidal anti-inflammatory drug including an adhesive layer composed of a transdermal preparation on a support, the transdermal preparation including a) 10 to 40% by weight of a non-aqueous base material based on the total weight of the transdermal preparation, b) 1 to 10% by weight of a non-steroidal anti-inflammatory drug based on the total weight of the transdermal preparation, and c) a polyethylene glycol component composed of 0.3 to 5% by weight of a low molecular weight polyethylene glycol based on the total weight of the transdermal preparation, and 1 to 10% by weight of a high molecular weight polyethylene glycol based on the total weight of the transdermal preparation.. .
11/13/14
20140335091
Anti-glucagon receptor antibodies and methods of use thereof
The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome..
11/13/14
20140335037
Aqueous oxidizing composition
Present invention relates to an aqueous oxidizing composition comprising at least one oxidizing, at least one alkyl or alkanol amine, urea, at least one carbonate salt and at least one natural triglyceride. Composition comprises furthermore hair dyes..
11/13/14
20140333001
Thermoplastic polyurethane with reduced tendency to bloom
The present invention discloses a thermoplastic polyurethane which is comprised of the reaction product of (1) a hydroxyl terminated polyester intermediate, (2) a polyisocyanate, and (3) a glycol chain extender; wherein the hydroxyl terminated polyester intermediate is comprised of repeat units that are derived from 1,3-propylene glycol and a dicarboxylic acid; wherein the hydroxyl terminated polyester intermediate has a number average molecular weight from 500 to 10,000; and wherein the thermoplastic polyurethane includes hard segments that are the reaction product of the polyisocyanate and the glycol chain extender. This thermoplastic polyurethane is unique in that it has a greatly reduced tendency to bloom.
11/13/14
20140332209
Polyol for improving sweep efficiency in oil reservoirs
The proposed method is an improved chemical flooding of an oil reservoir, especially one containing heavy oil or bitumen, that is cheaper than traditional chemical flooding techniques. This is obtained by viscosifying the displacing phase with a polyol, such as glycerol and/or its derivatives.
11/06/14
20140330246
Intrauterine fetal growth restriction - the biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements
Intrauterine fetal growth restriction (iugr) is an affliction of a disparaging spectrum, placental insufficiency being the major inciting pathology. The resultant fetal hypoglycemia is alleviated by intravenous hypertonic d-glucose 25-50% maternal supplements, by improving the vmax of placental transfer for d-glucose, in accordance with michaelis-menten model of substrate transfer.
11/06/14
20140330039
Method for recovering and purifying propionic acid
The present invention provides a method for purifying and recovering propionic acid from an aqueous mixture containing a fermentation product obtained from a fermentation process using glycerol as substrate, the method comprising optionally acidifying the aqueous mixture to a ph below 4.5, subjecting the aqueous mixture to an extraction with extracting agent containing a heavy extractant and optionally a light extractant as a diluent to obtain an extract comprising the extracting agent and organic acids, and a raffinate comprising water and any unreacted glycerol, and subjecting the extract to vacuum evaporation to separate propionic acid-containing organic acids from the extractant.. .
11/06/14
20140330033
Mechanically enhanced separation of reaction products in biodiesel production
Apparatus and related methods for reacting a natural oil with a short chain alcohol in the presence of an alkaline catalyst and mesh to produce biodiesel, significantly decreasing the amount of time for the glycerol byproduct to settle out of the reaction mixture. The process for the production of biodiesel includes providing animal or vegetable oil to create a first component, combining a short chain alcohol with a strong base to create a second component, and combining the first and second components together in the presence of a mesh, such that the mesh is in contact with the combined components.
11/06/14
20140330003
Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae
The present disclosure relates to the isolation, purification, and characterization of a diacylglycerol acyltransferase 2 (dgat2), and genes encoding dgat2, from algae. Dgat2 can incorporate very long-chain polyunsaturated fatty acids into triacylglycerol more efficiently than dgat1.
11/06/14
20140329994
Branched polymers
The present invention is directed to branched reactive water-soluble polymers comprising at least two polymer arms, such as poly(ethylene glycol), attached to a central aliphatic hydrocarbon core molecule through heteroatom linkages. The branched polymers bear at least one functional group for reacting with a biologically active agent to form a biologically active conjugate.
11/06/14
20140329904
Increasing the bioavailability of hydroxycinnamic acids
The present invention generally relates to the field of nutrition, health and wellness. For example, the present invention relates to hydroxycinnamic acids and their health benefits.
11/06/14
20140329774
Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof
The present invention includes an injectable composition containing phosphatidylcholine including phosphatidylcholine; ethanol; propylene glycol and/or benzyl alcohol; polysorbate and/or macrogol 15 hydroxystearate; and a balance of water or water for injection, and a preparing method thereof. An injectable composition of the present invention includes no sodium deoxycholate, which is carcinogenic, and therefore a safer injectable composition of phosphatidylcholine can be prepared..
11/06/14
20140329759
Polyethylene glycol-modified integrin blocker hm-3 and use thereof
The present invention involves the pharmaceutical field, including integrin antagonists, which have the capacities of inhibiting angiogenesis of tumors, binding integrin. These antagonists are a kind of polypeptide, which was modified by polyethylene glycol and after modification, it can be used to treat tumors.
11/06/14
20140329749
Robust controlled-release peptide formulations
The present invention relates to compositions forming a low viscosity mixture of: a. 25-55 wt.
11/06/14
20140329735
Fragrancing composition of pickering emulsion type
The present invention relates to a composition in the form of an oil-in-water emulsion, comprising, in a cosmetically acceptable medium: (i) a dispersed oily phase comprising at least one apolar hydrocarbon-based oil; (ii) a continuous aqueous-alcoholic phase comprising at least one c1-c4 monoalcohol; (iii) at least 1% by weight of fragrancing substance(s), relative to the total weight of the said composition; (iv) magnesium silicate particles; and (v) at least one polyalkylene glycol.. .
11/06/14
20140329304
Rapid peptidoglycan-based assay for detection of bacterial contamination
The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-β-d-glucan in a sample.. .
11/06/14
20140329290
Novel branched polyethylene glycol and use thereof
The present invention allows formation of covalent bonds in a bioactive compound having at least one amino group so as to efficiently provide the compound modified with peg. The present invention thus provides a functionalized polyethylene glycol having a structure that allows reaction of two aldehyde groups with one amino group to form two covalent bonds..
11/06/14
20140329281
Recombinant production of steviol glycosides
Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express recombinant genes encoding udp-glycosyltransferases (ugts). Such microorganisms, plants, or plant cells can produce steviol glycosides, e.g., rebaudioside a and/or rebaudioside d, which can be used as natural sweeteners in food products and dietary supplements..
11/06/14
20140329276
Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
Methods for increasing the yield and n-glycosylation site occupancy of paucimannose or complex n-glycans of recombinant glycoproteins produced in a recombinant host cell lacking dolichyl-p-man:man5glcnac2-pp-dolichyl alpha-1,3 mannosyltransferase (alg3p) activity are disclosed. In particular, recombinant host cells are provided that comprise a disruption of the expression of an os-9 family gene in the host cell.
11/06/14
20140328976
Enzymatically hydrolysed lipids as flavour ingredients
A process for preparing a flavour concentrate having a meat flavour and/or aroma, comprising contacting animal lipid with a lipase enzyme, such that at least some triglycerides present in the lipid are hydrolysed, to give a mixture of free fatty acids, monoglycerides, diglycerides and non-hydrolyzed triglycerides; heating the mixture to inactivate the lipase; and heating the mixture with an aqueous solution containing at least one reducing sugar and at least one amino acid to give the flavour concentrate.. .
11/06/14
20140328953
Skin preparation composition for external use having excellent antiseptic ability
The present invention relates to a skin preparation composition for external use having excellent antiseptic ability without using chemical antiseptics. More particularly, the present invention relates to a skin preparation composition for external use, comprising: glyceryl undecylenate having excellent antiseptic ability; and one or more mixtures of ethylhexylglycerin, glyceryl caprylate, p-anisic acid and a citrus mixed extract, thus improving antiseptic ability through the increased effects of antiseptic abilities of those materials..
11/06/14
20140328947
Caustic agricultural compositions
An aqueous teat dip composition includes significant amounts of glycerin and preferably ethanol and has a ph of at least 8.5. The aqueous teat dip composition can be provided by a method that involves delivering a basic concentrate to a site where dairy animals are located where the concentrate is mixed with water before the ph of the resulting solution is upwardly adjusted.
11/06/14
20140328885
Sheet for cutaneous application containing vitamin e or an ester thereof
Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin e or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated c8-c18 fatty acids.. .
11/06/14
20140328791
Conjugates of an il-2 moiety and a polymer
Conjugates of an il-2 moiety and one or more nonpeptidic, water-soluble polymers are provided. Typically, the nonpeptidic, water-soluble polymer is poly(ethylene glycol) or a derivative thereof.
11/06/14
20140328759
Limit size lipid nanoparticles and related methods
Various lipid nanoparticles are disclosed, including nanoparticles comprising a lipid bilayer comprising a phospholipid, a sterol, a polyethylene glycol-lipid surrounding an aqueous core which comprises a therapeutic and/or diagnostic agent and nanoparticles comprising a lipid monolayer surrounding a hydrophobic core. Of particular interest are limit size lipid nanoparticles with a diameter from 10-100 nm.
11/06/14
20140328737
Cobalt extraction method
The objective of the present invention is to selectively extract cobalt from an acidic solution containing a high concentration of manganese. This cobalt extraction method extracts cobalt from an acidic solution containing manganese and cobalt by subjecting the acidic solution to solvent extraction by means of a valuable metal extraction agent comprising an amide derivative represented by general formula (i).
11/06/14
20140326659
Preparation method of enhanced-type polyacrylonitrile hollow fiber membrane
A preparation method of an enhanced-type polyacrylonitrile hollow fiber membrane comprises steps of: (1) knitting a polyacrylonitrile fiber hollow braided tube by a two-dimensional weaving technology; wherein the polyacrylonitrile fiber hollow braided tube is utilized as a reinforcement of a hollow fiber membrane; (2) preparing polyacrylonitrile casting solution, wherein, polyacrylonitrile resin is 3%-25%; solvent is 50%-95%; and additive is 2%-30%; a sum of the mass percent of all composition mentioned above is 100%; (3) infiltrating the polyacrylonitrile fiber hollow braided tube by weak polar organic liquid, wherein, a time of the polyacrylonitrile fiber hollow braided tube infiltrated is is-60s; the weak polar organic liquid is ethanol, glycerol, isopropanol, or polyethylene glycol (peg)-600; (4) processing the polyacrylonitrile fiber hollow braided tube and the polyacrylonitrile casting solution with a coextrusion by an annular spinneret; fully solidifying the polyacrylonitrile fiber hollow braided tube and the polyacrylonitrile casting solution in coagulation bath; in such a manner that an enhanced-type polyacrylonitrile hollow fiber membrane is obtained.. .
11/06/14
20140325898
Method to optimize biodiesel production
Apparatus and related methods for reacting a natural oil and salt composition with a short chain alcohol in the presence of an alkaline catalyst to produce biodiesel, significantly decreasing the amount of time for the glycerol byproduct to settle out of the reaction mixture. The process for the production of biodiesel includes combining animal or vegetable oil with a salt to create a first component, combining a short chain alcohol with a strong base to create a second component, and combining the first and second components together.
10/30/14
20140325697
Glyphosate tolerant corn event vco-o1981-5 and kit and method for detecting the same
The invention particularly concerns an elite transformation event vco-Ø1981-5 comprising the gene construct and means, kits and methods for detecting the presence of the said elite event.. .
10/30/14
20140323956
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
The present invention relates to recombinant adeno-associated virus (raav) delivery of an alpha-sarcoglycan gene. The invention provides raav products and methods of using the raav in the treatment of limb girdle muscular dystrophies such as lgmd2d..
10/30/14
20140323774
Method of making alcohols
A method of making one or more alcohols with a single hydroxy group, such as methanol and ethanol, the method comprising contacting a polyol and water with a basic catalyst. The polyol may be glycerol, for example.
10/30/14
20140323699
Method of detecting cancer based on glycan biomarkers
The present invention provides a method for labeling or detecting a protein with certain glycosyl groups. The methods are particularly useful for detecting cancer cells comprising the detected glycosyl groups.
10/30/14
20140323594
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of cytoplasmic aspartate aminotransferase, soluble tumor necrosis factor receptor superfamily member 5, soluble cd40 ligand, soluble c-x-c motif chemokine 16, s100-a12, eotaxin, soluble e-selectin, fibronectin, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, heparin-binding growth factor 2, soluble hepatocyte growth factor receptor, interleukin-1 receptor antagonist, interleukin-1 beta, interleukin-10, interleukin-15, interleukin-3, myeloperoxidase, nidogen-1, soluble oxidized low-density lipoprotein receptor 1, pappalysin-1, soluble p-selectin glycoprotein ligand 1, antileukoproteinase, soluble kit ligand, tissue inhibitor of metalloproteinase 1, tissue inhibitor of metalloproteinase 2, soluble tumor necrosis factor, soluble vascular cell adhesion molecule 1, and vascular endothelial growth factor a as diagnostic and prognostic biomarkers in renal injuries..
10/30/14
20140323574
Infant formula with high sn-2 palmitate and oligofructose
An infant formula having a relatively high content of triglycerides having palmitic acid in the sn-2 position. The formula may include oligofructose.
10/30/14
20140323497
Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
This invention is directed to methods of inhibiting coagulation or treating thrombosis using a factor xa inhibitor and a p-glycoprotein (pgp) inhibitor. The invention is also directed to formulations used in the methods..
10/30/14
20140323472
Methods and compositions for the delivery of a therapeutic agent
The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration.
10/30/14
20140323449
Enema composition for treatment of ulcerative colitis having long term stability
Long term storage stable budesonide-containing solutions are disclosed. The solutions can include budesonide or a pharmaceutically acceptable salt thereof, cromolyn sodium, antioxidizing agent, benzoic acid, and a pharmaceutically acceptable fluid including propylene glycol and water.
10/30/14
20140323432
Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
Specifically disclosed are a cartilage production promoter, a glucosaminoglycan and/or proteoglycan production promoter, and a prophylactic or therapeutic agent for diseases associated with cartilage damage, each of which comprises fucoidan as an active ingredient.. .
10/30/14
20140323423
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders...
Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible.
10/30/14
20140323422
Anionic conjugates of glycosylated bacterial metabolite
The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (gags). The invention also relates to processes for the preparation of the conjugates.
10/30/14
20140323379
Washing and cleaning agents containing glycerin esters
It has been discovered according to the present invention that glycerol esters effectively prevent or at least decrease the discoloration of plastic dishes in the context of automatic dishwashing.. .
10/30/14
20140323373
Novel sulphur-bridged compounds, use thereof and process for production thereof
The present invention relates to novel sulphur-bridged compounds, in which within the molecule there is at least one fatty acid bonded by way of at least one sulphur bridge to at least one polyalkylene glycol ester, the reaction product of a fatty acid with a polyalkylene glycol, and these have from 8 to 29% by weight sulphur content, to use of these as sulphur carrier and lubricant additive and to production of the said compounds.. .
10/30/14
20140323324
Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
The purpose of the present invention is to develop: a method for selectively separating a glycoprotein derived from the central nervous system from a body fluid or a central nervous system cell; and a method for searching for an index marker for central nervous system diseases, which utilizes the aforementioned method. A protein derived from the central nervous system, which occurs in a trace amount in a body fluid or a central nervous system cell, can be selectively enriched by a two-stage separation procedure comprising removing a glycoprotein having sialic acid at a non-reducing terminal thereof from the body fluid or the central nervous system cell and then separating a glycoprotein having n-acetylglucosamine at a non-reducing terminal thereof..


Popular terms: [SEARCH]

Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2938

3873

0 - 1 - 82